Policy Statements

June 13, 2025

Statement on HHS Replacement of All ACIP Members

May 29, 2025

Statement on HHS Recommendations Regarding COVID-19 Vaccination During Pregnancy

April 28, 2025
Letter to Hill leadership in support of HR 1672, the "MINI Act," to advance research and investment in genetically targeted technology for rare, complex, and hard-to-treat conditions that disproportionately impact women

November 15, 2023
Statement on the White House Initiative on Women’s Health Research Announcement

May 15, 2023
Letter of support on the essential importance of HPV vaccination to cervical cancer reduction in the relaunched Cancer Moonshot effort

October 19, 2022
Comments to the FDA’s Center for Drug Evaluation and Research, Advisory Committee hearing on its proposed market withdrawal of Makena and its five generic forms, the only class of treatments to help prevent spontaneous, recurrent preterm birth

October 13, 2022
Letters to First Lady, Dr. Jill Biden, and the Congressional members who are leading efforts to give women more access to DXA scans, to encourage them to get involved in our YesYouScan campaign

July 20, 2022
Letter to the FDA in concern over the limited options that are available for protection against COVID-19

April 13, 2022
Statement of support for Black Maternal Health Week (BMHW) to help raise awareness and amplify the voices and needs of Black mamas everywhere

April 8, 2022
Comments to inform the CDC Clinical Practice Guideline for Prescribing Opioids

April 5, 2022
Comment to the FDA’s Vaccines and Related Biological Products Advisory Committee (Vrbpac) in support of the use of COVID-19 booster doses to protect Americans from COVID-19

April 4, 2022
Statement on White House Decisions to Expand Medicaid PostPartum Coverage

October 11, 2021
Statement on Dr. Francis S. Collins' Impending Departure From the National Institutes of Health

September 29, 2021
Comments to September 29, 2021, ACIP CDC Meeting

September 21, 2021
Comments to the NIH for its meeting, "Advancing NIH Research on the Health of Women: A 2021 Conference," to identify gaps in research and pitfalls in clinical practice when it comes to maternal health, chronic debilitating conditions in women and cervical cancer survival rates

August 9, 2021
Pneumococcal Vaccine Statement

May 10, 2021
Letter in support of National Women's Health Week (NWHW)

April 9, 2021
Letter in support of Black Maternal Health Week

March 10, 2021
Letter to Joint Arthritis Advisory Committee in support of nonaddictive treatment for chronic pain in support of nonaddictive treatment for chronic pain

February 28, 2021
Statement for Dr. Anita Gupta

October 21, 2020
Statement on Proposal to Withdraw Only FDA-Approved Treatment Option for Preterm Birth

September 4, 2020
Letter to the FDA and NIH on Chronic Pain Treatment Options

August 27, 2020
Statement on Uterine Fibroid Research and Education Act (SB 4397)

August 21, 2020
New American Cancer Society Cervical Cancer Screening Guidelines: Statement from HealthyWomen CEO Beth Battaglino, RN-C

June 26, 2020
Statement on the Trump Administration's Request to Overturn the Affordable Care Act